Marcus Today's Henry Jennings and Atlas Funds Management's Hugh Dive reflect on the year that was, and cast an eye towards 2025.

However, she does have a word of warning ... shelf life of canned products by storing them in a cool and dark area. Packaged salad: As long as your salad leaves haven't gone mouldy (wilted ...

In Europe, the EU Pharmaceutical Legislation package will reduce orphan exclusivity ... new shape of the pharmaceutical market for years to come becomes apparent. Readout from NEXUS study sets ...

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...

These weight loss drugs are expensive out of pocket, though. Even with insurance, high co-pays can also limit who has access ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

Recently, weight loss drugs like Ozempic and Wegovy have gained widespread attention, transforming the landscape of obesity management and weight loss treatments. Initially developed for the treatment ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional — and often ineffective — advice ...